Vedolizumab in Indian patients with Inflammatory Bowel Disease: Interim results from a prospective, multicentre, open-label, phase 4 study

Category Primary study
JournalJournal of Crohn's and Colitis
Year 2024
This article has no abstract
Epistemonikos ID: 96e82ec81692b835e99fee0c8b445e4e79ef39f6
First added on: Feb 17, 2025